Insulin aspart
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | <StructureSection load='' size='340' side='right' caption='PDB ID [[4gbc]]' scene='96/968809/Cv/3'> | + | <StructureSection load='' size='340' side='right' caption='Human modified insulin complex with cresol Zn+2 and Cl-; PDB ID [[4gbc]]' scene='96/968809/Cv/3'> |
Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart] and [[Insulin]]. | Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart] and [[Insulin]]. | ||
Revision as of 09:57, 17 January 2024
| |||||||||||
